** Shares of Challenger CGF.AX rise 2.5% to A$7.055, set for fourth session of consecutive gains
** Insurer on Thursday reported a 20% jump in Q3 total life annuity sales at A$991 million
** Macquarie notes that the firm's retail annuity sales grew by 2% y-o-y while institutional annuity sales surged by 200%, reflecting its strategic focus on longer maturity and higher-margin business
** Macquarie raises its price target A$7 from A$6.60, while maintaining "Outperform" rating
** Brokerage also highlights that Japanese sales contributed ~24.2% of the Q3 sales, indicating CGF's significant market presence in Japan
** Stock up 17.6% YTD
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.